Published in Am J Hematol on March 01, 2010
Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood (2010) 1.76
Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group. Haematologica (2011) 1.06
Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography. Helicobacter (2015) 0.93
Applicability of 2009 international consensus terminology and criteria for immune thrombocytopenia to a clinical pediatric population. Pediatr Blood Cancer (2011) 0.93
Solar radiation and vitamin D: mitigating environmental factors in autoimmune disease. J Environ Public Health (2012) 0.92
Rituximab for children with immune thrombocytopenia: a systematic review. PLoS One (2012) 0.89
Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol (2012) 0.88
Clinical practice: immune thrombocytopenia in paediatrics. Eur J Pediatr (2014) 0.88
Positioning new treatments in the management of immune thrombocytopenia. Pediatr Blood Cancer (2012) 0.82
Romiplostim as a treatment for immune thrombocytopenia: a review. J Blood Med (2015) 0.82
Determining a definite diagnosis of primary immune thrombocytopenia by medical record review. Am J Hematol (2012) 0.81
Immune thrombocytopenia. Hematol Oncol Clin North Am (2013) 0.81
Cost effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Ireland. Appl Health Econ Health Policy (2013) 0.78
Significance of periodontal health in primary immune thrombocytopenia- a case report and review of literature. J Dent (Tehran) (2013) 0.77
High dose Intravenous Anti-D Immune Globulin is More Effective and Safe in Indian Paediatric Patients of Immune Thrombocytopenic Purpura. J Clin Diagn Res (2016) 0.75
Rate of bleeding-related episodes in adult patients with primary immune thrombocytopenia: a retrospective cohort study using a large administrative medical claims database in the US. Clin Epidemiol (2016) 0.75
Low-level light treatment ameliorates immune thrombocytopenia. Sci Rep (2016) 0.75
Laparoscopic splenectomy for primary immune thrombocytopenia: Current status and challenges. World J Gastrointest Endosc (2016) 0.75
A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment. Drug Saf Case Rep (2015) 0.75
Safety and immunogenicity of an intramuscular quadrivalent influenza vaccine in children 3 to 8 y of age: A phase III randomized controlled study. Hum Vaccin Immunother (2016) 0.75
Importance of immature platelet fraction as predictor of immune thrombocytopenic purpura. Pak J Med Sci (2016) 0.75
Spotlight on romiplostim in the treatment of children with chronic immune thrombocytopenia: design, development, and potential place in therapy. Drug Des Devel Ther (2017) 0.75
Pathogenesis-oriented approaches for the management of corticosteroid-resistant or relapsedprimary immune thrombocytopenia. Open Med (Wars) (2016) 0.75
Immune thrombocytopenia after bee venom therapy: a case report. BMC Complement Altern Med (2016) 0.75
Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational Cohort. Front Pediatr (2015) 0.75
Combination therapy of rituximab and corticosteroids for patients with refractory chronic immune thrombocytopenic purpura: report of two cases. Contemp Oncol (Pozn) (2013) 0.75
Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP). J Clin Med (2017) 0.75
The Efficacy of Colchicine and Dapsone Combination Therapy in Relapsed Immune Thrombocytopenia. Hematol Rep (2017) 0.75
MicroRNA-125-5p targeted CXCL13: a potential biomarker associated with immune thrombocytopenia. Am J Transl Res (2015) 0.75
A Case Report of an Elderly Woman With Thrombocytopenia and Bilateral Lung Infiltrates: A Rare Association Between Diffuse Alveolar Hemorrhage and Idiopathic Thrombocytopenic Purpura. Medicine (Baltimore) (2015) 0.75
A dengue infection without bleeding manifestations in an adult with immune thrombocytopenic purpura. Trop Med Health (2016) 0.75
Intermittent low platelet counts hampering diagnosis of X-linked thrombocytopenia in children: report of two unrelated cases and a novel mutation in the gene coding for the Wiskott-Aldrich syndrome protein. BMC Pediatr (2017) 0.75
Role of platelet function and platelet membrane glycoproteins in children with primary immune thrombocytopenia. Mol Med Rep (2016) 0.75
Effect of short-term, high-dose methylprednisolone on oxidative stress in children with acute immune thrombocytopenia. Blood Res (2016) 0.75
Proactive use of eltrombopag before the onset of clinical bleeding in two children with immune thrombocytopenia and lifestyle restrictions. Clin Case Rep (2017) 0.75
Immunomodulatory treatments for persistent and chronic immune thrombocytopenic purpura: A PRISMA-compliant systematic review and meta-analysis of 28 studies. Medicine (Baltimore) (2017) 0.75
Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med (2009) 5.48
Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med (2010) 5.23
Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med (2011) 4.76
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc (2015) 4.70
Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern Med (2013) 4.25
Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAMA (2013) 4.25
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med (2006) 4.07
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet (2008) 3.74
Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood (2009) 3.18
Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med (2007) 3.17
Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children. Pediatrics (2008) 2.42
Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med (2008) 2.31
Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings. Chest (2004) 2.30
Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood (2008) 2.17
Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood (2008) 2.13
Recent advances in thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program (2004) 1.94
Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications. Med Care (2010) 1.88
Parental communication and youth sexual behaviour. J Adolesc (2006) 1.87
Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica (2007) 1.87
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion (2004) 1.84
Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood (2010) 1.76
A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease. J Natl Med Assoc (2009) 1.70
Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Ann Intern Med (2004) 1.69
Induction of fetal hemoglobin synthesis in children with sickle cell anemia on low-dose oral sodium phenylbutyrate therapy. J Pediatr Hematol Oncol (2002) 1.65
Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography. Ann Intern Med (2003) 1.65
Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea. Am J Hematol (2006) 1.61
Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery. J Am Coll Cardiol (2011) 1.59
Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol (2009) 1.56
Drug-induced thrombocytopenia: an updated systematic review, 2008. Drug Saf (2009) 1.52
Accuracy of CT in the diagnosis of pulmonary embolism: a systematic literature review. AJR Am J Roentgenol (2004) 1.51
Youth-parent communication and youth sexual behavior: implications for physicians. Fam Med (2006) 1.50
Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept. Am J Hematol (2003) 1.50
Impact of bariatric surgery on health care utilization and costs among patients with diabetes. Med Care (2012) 1.49
Older patients with diverticulitis have low recurrence rates and rarely need surgery. Surgery (2011) 1.48
Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis. Ann Intern Med (2016) 1.47
Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood (2014) 1.47
Validating the adapted Diabetes Complications Severity Index in claims data. Am J Manag Care (2012) 1.47
Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review. Pharmacoeconomics (2010) 1.46
Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist (2007) 1.45
Analytic validity of genetic tests to identify factor V Leiden and prothrombin G20210A. Am J Hematol (2010) 1.40
Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica (2007) 1.39
Management of immune thrombocytopenia--something old, something new. N Engl J Med (2010) 1.39
The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract (2004) 1.34
Relationships among youth assets and neighborhood and community resources. Health Educ Behav (2005) 1.28
Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks. J Cardiovasc Electrophysiol (2002) 1.27
Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion (2012) 1.27
Tobacco use among American Indians in Oklahoma: an epidemiologic view. Public Health Rep (2005) 1.26
Syndromes of thrombotic microangiopathy. N Engl J Med (2014) 1.25
Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev (2013) 1.20
Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery. Arch Surg (2010) 1.19
A comparison of active adverse event surveillance systems worldwide. Drug Saf (2014) 1.19
Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review. Transfusion (2007) 1.19
Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members. Arthritis Rheum (2012) 1.19
Recurrent acute thrombocytopenia in the hospitalized patient: sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia. Am J Hematol (2010) 1.18
Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer (2013) 1.16
Venous thromboembolism in patients with HIV/AIDS: a case-control study. J Acquir Immune Defic Syndr (2008) 1.14
Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion (2006) 1.14
Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood (2013) 1.13
The epidemiology of immune thrombocytopenic purpura. Curr Opin Hematol (2007) 1.13
Reliability and validity of the youth asset survey (YAS). J Adolesc Health (2002) 1.12
Building capacity to address tobacco-related disparities among American Indian and Hispanic/Latino communities: conceptual and systemic considerations. Addiction (2007) 1.12
Hydroxyurea for the treatment of sickle cell disease. Evid Rep Technol Assess (Full Rep) (2008) 1.11
Faculty involvement in translational research and interdisciplinary collaboration at a US academic medical center. J Investig Med (2010) 1.11
Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol (2011) 1.10
The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS. Semin Hematol (2004) 1.09
Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura. Transfusion (2009) 1.09
Does participation in a nurse visitation programme reduce the frequency of adverse perinatal outcomes in first-time mothers? Paediatr Perinat Epidemiol (2005) 1.08
Thrombocytopenia as an adverse effect of complementary and alternative medicines, herbal remedies, nutritional supplements, foods, and beverages. Eur J Haematol (2010) 1.08
Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review. Pediatrics (2013) 1.07
Predictors of statin compliance after switching from branded to generic agents among managed-care beneficiaries. J Gen Intern Med (2014) 1.07
Patient-reported outcomes (PROs): putting the patient perspective in patient-centered outcomes research. Med Care (2013) 1.06
Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients. Br J Haematol (2008) 1.03
High prevalence and correlates of low bone mineral density in young adults with sickle cell disease. Am J Hematol (2006) 1.03
Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med (2007) 1.03
Effect of childhood obesity prevention programs on blood pressure: a systematic review and meta-analysis. Circulation (2014) 1.02
Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials. Depress Anxiety (2014) 1.01
Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity. Blood (2002) 1.00
Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus. South Med J (2007) 1.00
Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity. Br J Haematol (2007) 1.00
Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica (2011) 0.99